Join leading experts Dr Sharon Ford and Professor Steve Chadban for a practical exploration of C3G and primary IC-MPGN in the kidney transplant setting. This session will examine the challenges of disease recurrence following transplantation, including recognising and diagnosing disease in the allograft, approaches to monitoring and key considerations for the ongoing management of transplant recipients with C3G or primary IC-MPGN.

Dr. Chadban is Head of Renal Medicine at Royal Prince Alfred Hospital and Professor of Medicine at the University of Sydney. As a clinician-scientist, he leads research spanning basic science, clinical trials, and transplant outcomes and has published over 400 peer-reviewed papers (34,000+ citations; H-index 98). Dr. Chadban is Past-President of the Transplantation Society of Australia and New Zealand, past chair of ANZDATA, advises Government on Transplantation and CKD, and is co-chair of the 2020 KDIGO Clinical Guidelines for assessment and management of candidates for Kidney Transplantation. 

Dr Sharon Ford is the Deputy Director of Nephrology at The Austin Hospital, Melbourne, where she oversees the CKD program. Her previous positions include St Vincent’s Hospital Melbourne from 2015 – 2023 where she led the Transplant Assessment Clinic, the Nephrology Clinical Trials program and the General CKD Clinic and Monash Health from 2012-2016.

Sharon competed a PhD in 2023 at the Monash University Centre for Inflammatory Diseases investigating innate immune mechanisms of the pathogenesis of MPO-ANCA vasculitis, under the supervision of Dr Kim O’Sullivan, Professors Richard Kitching and Stephen Holdsworth and Dr Shaun Summers. Sharon was awarded the ANZSN Young Investigator award for her PhD research.

Sharon is ANZSN President, having previously undertaken ANZSN roles including Honorary Executive Officer, Councillor and Deputy Chair of Scientific Program and Awards Committee. Dr Ford is also the current chair of the TSANZ and Victorian Tasmania Transplantation Committee Vascularised Composite Allograft Subcommittee is the ANZSN representative on the Organ Tissue Authority Transplant Advisory Group.